| 英文别名 |
Phosphonomycin (R)-1-phenethylamine salt;(R)-alpha-Methylbenzenemethanamine (2R-cis)-(3-methyloxiranyl)phosphonate (1:1);[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid,(1R)-1-phenylethanamine;Fosfomycin phenylethylamine;M-1513;Q423;3-METHYL-2-BUTENE-1-AMINEHCL;Fosfomycin (R)-1-phenethylamine;50V5RBU89I;(R)-1-phenylethan-1-amine ((2R,3S)-3-methyloxiran-2-yl)phosphonate;AS-15719;(R)-alpha-Phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate;AKOS025311516;EC 418-570-8;25383-07-7;UNII-50V5RBU89I;E78444;[(2R,3S)-3-Methyloxiran-2-yl]phosphonic acid--(1R)-1-phenylethan-1-amine (1/1);(1R)-1-phenylethan-1-amine; [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid;Fosfomycin (R)-1-phenethylamine salt;Levo-phosphonomycin (R)-1-phenethylamine salt;DTXSID80726231;J-015973;Q27260828;[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid;(1R)-1-phenylethanamine;CS-0199057;Phosphonic acid, P-[(2R,3S)-3-methyl-2-oxiranyl]-, compd. with (aR)-a-methylbenzenemethanamine (1:1); Phosphonic acid, (1,2-epoxypropyl)-, cis-(-)-, compd. with (+)-a-methylbenzylamine (1:1) (8CI); Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-, compd. w;ODALAXKSIBESFV-PXRNWTNJSA-N |